Emyria Limited

ASX (AUD): Emyria Limited (EMD)

Last Price

0.031

Today's Change

+0.002 (6.89%)

Day's Change

0.029 - 0.031

Trading Volume

7,752,189

Overview

Market Cap

18 Million

Shares Outstanding

611 Million

Avg Volume

1,612,859

Avg Price (50 Days)

0.03

Avg Price (200 Days)

0.03

PE Ratio

-1.03

EPS

-0.03

Earnings Announcement

27-Jul-2025

Previous Close

0.03

Open

0.03

Day's Range

0.029 - 0.031

Year Range

0.021 - 0.05

Trading Volume

7,752,189

Price Change Highlight

1 Day Change

6.90%

5 Day Change

14.81%

1 Month Change

24.00%

3 Month Change

0.00%

6 Month Change

-6.06%

Ytd Change

-13.89%

1 Year Change

-36.73%

3 Year Change

-84.72%

5 Year Change

-40.57%

10 Year Change

-77.87%

Max Change

-77.87%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Health Information Services

Description:

Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment